StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Company News for GlaxoSmithKline PLC - Essay Example

Cite this document
Summary
The paper "Company News for GlaxoSmithKline PLC" suggests that GlaxoSmithKline (GSK) is one of the biggest names in the pharmaceutical industry and currently GSK is a dominant business group in the pharmaceutical sector. GSK offers various varieties of medicines and vaccines…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER94% of users find it useful
Company News for GlaxoSmithKline PLC
Read Text Preview

Extract of sample "Company News for GlaxoSmithKline PLC"

GlaxosmithKline (GSK) is one of the biggest s in the pharmaceutical industry and currently GSK is a dominant business group in the pharmaceuticalsector. GSK offers various varieties of medicines and vaccines. GSK’s caters to patients suffering from various diseases, such as cancer, cold, asthma, allergies, migraine and herpes etc. In addition, GSK, like any other successful pharmaceutical company, places a lot of emphasis on research and development (R&D) in order to provide medicines that are a result of the latest research in medical science. GSK has also introduced a wide range of health and food products such as energy drinks. GSK also owns and markets Aquafresh range of toothpastes, which may help smokers quit smoking. GSK’s principal pharmaceutical products include medicines in the therapeutic areas, such as respiratory, central nervous system, anti-virals, anti-bacterials, metabolic, vaccines, cardiovascular and urogenital. GSK has operated its business in 114 countries and sold products over 150 countries. The GSK operates in two segments: Pharmaceuticals and Consumer Healthcare. On June 5, 2008, GSK acquired Sirtris Pharmaceuticals Inc., a biopharmaceutical company. On October 14, 2008, group also acquired the Egyptian mature products business of Bristol Myers Squibb (BMS). NEWS & STORIES According to Reuters on Tuesday, 31 Mar 2009, GlaxoSmithkline PLC won final European approval for its new childhood vaccine Synflorix for preventing pneumococcal disease (Reuters, 2009). Reuters reported that on Tuesday, 31 Mar 2009, Shire plc has entered into a joint promotional agreement with GlaxoSmithKline plc for VYVANSE (lisdexamfetamine dimesylate) capsules. The aim behind this promotional agreement is to improve recognition and treatment of ADHD in adults. (Reuters, 2009) On Wednesday, 25 Mar 2009 Reuters reported that GSK plans to take a significant stake in Aspen Pharmacare Holdings Limited. The reason behind this stake is to cement its current relationship into a long term bond which really makes a significant impression on the equity of both the companies. (Reuters, 2009) According to Reuters on Friday, 20 Mar 2009, GSK plc announced that it has sold 5,749,157 shares of common stock, par value of $0.01 per share, of Quest Diagnostics Inc. (Reuters, 2009) QUALITATIVE ISSUES GSK faces several issues that are concerns for the management. Some of these issues are described below: Issues related to the Environment, health and safety are subject to the primary and core issue because the business in which GSK deals is very much sensitive due to its attachment with the humanitarian side of the picture. So GSK’s needs to ensure that their products are neither injurious for health and nor for the environment. Lawsuits filed by patients, can be a result of adverse after-effects of any drug, which may bring a bad name and reputation for the firm, hence they need to ensure that no such window of risk is left open. The directors and senior management should give keen emphasis on practicing the corporate governance affairs, SEC rules and regulations that are imposed on every single business, meeting the accounting and audit standards in accordance with the international laws, and compliance affairs too. GSK’s SHARE PRICE (From 2004 – 2008) GSK’s share price is strengthening day by day due to their business operation which covers over 100 countries and also the ever-diversifying product line (Telegraph, 2009) makes a significant impression on their stock prices. Most of the brokers and stock analysts have estimated a bright future to GSK’s stock in the market (http://uk.finance.yahoo.com). All the analysts have suggested the existing stock holders to hold the current stock as GSK is expected to report its highest net income in the coming year which is why its value in the short and long run will probably rise (Telegraph, 2009). GSK’S CAPITAL & RESERVES The firm has reported the lowest capital in the year 2008, the reason behind which is the recession in the market world over, high prices of raw material, relatively high oil prices, etc, are prime factors behind this decrease in the capital reserves. While in the year 2007, which was very good for the pharmaceutical industry in general, GSK’s aggressive policies and cheapest availability of resources are the some of the factors that inflate the profits and in the end make a reflection on the capital. Other reserves amounted to £5,271 million at 31st December 2005 (2004 – £3,936 million, 2003 – £3,166 million) of which £8,067 million (2004 – £10,243 million, 2003 – £10,785 million) relates to the company and £180 million (2004 – £108 million, 2003 – £93 million) relates to joint ventures and associated undertakings. (GSK, Annual Report, 2005, pg 117). Other reserves include merger reserves, capital redemption reserves and the share buy-back programs, which result in negative figures for both the years 2005 and 2004 (GSK, Annual Report, 2005, pg 118). RATIO ANALYSIS PROFITABILITY RATIO YEAR 2008 2007 2006 2005 2004 Gross Profit Ratio 76% 77% 78% 78% 78% Net Profit Ratio 19% 23% 23% 22% 20% Return on Capital Employed 6% 7% 6% 7% 7% (GSK, Annual Report, 2008-2004) LIQUIDITY RATIO YEAR 2008 2007 2006 2005 2004 Current Ratio 1.72 1.32 1.51 1.39 1.26 Acid Test Ratio 1.29 1.00 1.15 1.13 0.98 (GSK, Annual Report, 2008-2004) ACTIVITY RATIO YEAR 2008 2007 2006 2005 2004 Stock Turnover Ratio 1.62 1.89 2.17 2.18 1.99 Debtor Collection Ratio 11.47 10.73 9.82 10.69 10.00 Creditor Collection Ratio 18.90 17.41 16.43 17.72 16.05 (GSK, Annual Report, 2008-2004) SELECTION OF 4 RATIOS The reason to choose these ratios is to identify liquidity problems if any, highlight the company’s profitability over the recent years. The company’s inventory and cash cycles also play an important role in identifying its effectiveness over the years. CURRENT RATIO GSK’s current ratio is slightly tentative and indicates a lower margin of safety with respect to meeting current obligations. GSKs current ratio will not allow the management to take more debt as compared to previous years (Bized, 2009). PROFIT MARGIN Over the entire 5 year period, GSK’s profit margin has been quite stable. Although GSK has made significant additions to its product line and have tried to come up with innovative products using state of the art technology, which obviously adds to its R&D expenditure, but due to some international laws, foreign currency exchange risk, etc net profit margin has not increased (Bized, 2009). QUICK RATIO GSKs quick ratio is in stable condition through out the 5 year. Although GSK has a higher inventory but proper maintenance of working capital has ensured a fair quick ratio, which indicates a liquidity problem and is very difficult to take more debt in the future (Bized, 2009). GEARING RATIO YEAR 2008 2007 2006 2005 2004 Gearing Ratio 2 1 1 1 1 (GSK, Annual Report, 2008-2004) GSK’s gearing ratio suggests that there is a flow of consistency in the management’s policies. In the year 2008, gearing ratio is doubled with respect to other years, this is due to the macro factors that force the management into taking bold decisions like taking more long term debt, due to which the equity part has come under heavy pressure and makes an adverse effect on the gearing ratio. After reviewing the Centre for Interfirm Comparison (CFIC) website, one can conclude that there is a difference in the analysis described on the website in comparison with the ratio analysis we conducted earlier in this paper. The CIFC (2009) helps businesses in order to provide expertise in the planning, information against the rivals, survey’s and sets the benchmarks for the companies to ensure better quality by adopting the best business practices. While on the other hand, ratio analysis performs the financial task. It is the best tool to evaluate the company’s performance. According to CFIC (2009), it is the good indicator for the external stakeholders to have a sufficient idea of the company’s growth. CONCLUSION All in all, after reviewing the annual reports from 2004 to 2008, one can evaluate that the directors and senior management of GSK keenly practice the corporate governance affairs, SEC rules and regulations, and give a lot of emphasis on meeting the accounting and auditing standards in accordance with the international laws, and compliance affairs. References Bized (2009). Worksheet on the Interpretation of Final Accounts (Student Version). Available: http://www.bized.co.uk/learn/business/accounting/busaccounts/finalacc/student.htm. Last accessed 01,April,2009. CIFC (2009). The Centre for Interfirm Comparison. Available: http://www.cifc.co.uk. Last accessed 01,April,2009. GlaxoSmithKline. (2008). Annual Report. GlaxoSmithKline. (2007). Annual Report. GlaxoSmithKline. (2006). Annual Report. GlaxoSmithKline. (2005). Annual Report. GlaxoSmithKline. (2004). Annual Report. Reuters. (2009). GlaxoSmithKline PLC (London Stock Exchange). Available: http://www.reuters.com/finance/stocks/incomeStatement?stmtType=INC&perType=ANN&symbol=GSK.L. Last accessed 01 April 2009. Reuters. (2009). Company News for GlaxoSmithKline PLC. Available: http://www.reuters.com/finance/stocks/companyNews?symbol=GSK.L&date=03312009. Last accessed 01,April,2009. Telegraph. (2009). Quote for Glaxosmithkline Plc. Available: http://shares.telegraph.co.uk/quote/?epic=GSK. Last accessed 01 April 2009 Yahoo Finance (2009). Fundamentals for Glaxosmithkline Plc. Available: http://uk.finance.yahoo.com/q?s=gsk&m=L&d=. Last accessed 01, April, 2009. Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Report Essay Example | Topics and Well Written Essays - 1250 words - 3”, n.d.)
Report Essay Example | Topics and Well Written Essays - 1250 words - 3. Retrieved from https://studentshare.org/miscellaneous/1553407-report
(Report Essay Example | Topics and Well Written Essays - 1250 Words - 3)
Report Essay Example | Topics and Well Written Essays - 1250 Words - 3. https://studentshare.org/miscellaneous/1553407-report.
“Report Essay Example | Topics and Well Written Essays - 1250 Words - 3”, n.d. https://studentshare.org/miscellaneous/1553407-report.
  • Cited: 0 times

CHECK THESE SAMPLES OF Company News for GlaxoSmithKline PLC

Marketing Strategy of GlaxoSmithKline

The main aim of this study is to analyze the marketing strategies adopted by glaxosmithkline plc; a London-based pharmaceutical company (Chaffey et al.... The study would also analyze the factors affecting the marketing strategies implemented by glaxosmithkline plc.... ne of the leading pharmaceutical companies in the world is glaxosmithkline plc, a company that produces effective medicinal drugs for various diseases.... he company's top-selling prescription medicine includes Avandia and Paxil which are anti-depressant pills (glaxosmithkline plc, 2013a)....
12 Pages (3000 words) Essay

Mission Statement and Market Overview of GlaxoSmithKline Plc

The author of the paper "Mission Statement and Market Overview of glaxosmithkline plc" will begin with the statement that pharmaceutical companies are making a great contribution to the economy of the United Kingdom (UK), higher than most other high-tech industries.... One such pharma company is glaxosmithkline plc (GSK) which is a British multinational pharmaceutical company headquartered in London, UK.... The following essay elaborates the marketing plan of the company by describing the current scenario of the industry and also GSK....
10 Pages (2500 words) Essay

Challenges to the Pharmaceutical Industrys Blockbuster-Driven Business Model at GlaxoSmithKline

The model presents major challenges to all but the three largest organizations; glaxosmithkline plc, Pfizer Inc.... Assessment of how effective is glaxosmithkline's strategies for meeting these challenges.... This paper presents the challenges to the pharmaceutical industry's blockbuster-driven business model....
7 Pages (1750 words) Case Study

Business Performance of GlaxoSmithKline

This paper focuses on the business performance of glaxosmithkline (GSK).... In relation to the challenges associated with the pharmaceutical industry's blockbuster-driven business model, this report aims to inform the general public about the challenges and limitations of using the Blockbuster-Driven Business Model and how glaxosmithkline (GSK) is able to meet these challenges.... Based in Britain, glaxosmithkline (GSK) is a science-based health care company that aims to develop a wide range of medicines through product researches and innovation (GSK, 2013a)....
9 Pages (2250 words) Case Study

KM at GlaxoSmithKline and McKinsey & Co

This paper discusses the knowledge management (KM) practices at two global companies that are acknowledged to be leaders in their respective fields: the pharmaceutical giant glaxosmithkline plc (GSK) and the management consulting firm McKinsey & Co. ... SK resulted from the 2000 merger between two English global healthcare businesses - Glaxo Wellcome plc and SmithKline Beecham plc -, and has its headquarters in London, two operational headquarters in the U....
11 Pages (2750 words) Essay

Pharmaceutical Companies Listed in London Stock Exchange

7) glaxosmithkline (hereafter referred to as GSK) and Pfizer have been close competitors for a long time, although their major focus in terms of the type of drug differs substantially, these two companies still compete for the top spot within many drug categories.... evertheless, both these companies are very accomplished: Pfizer is more often in the news as compared to any of its counterparts, mostly it generates media for all the wrong reasons, but it gets lots of free publicity nonetheless....
17 Pages (4250 words) Essay

Ethics of Marketing - Standards and Principles Tied with Suitable Conduct in the Market

this study will take a look at glaxosmithkline, which is a UK-based pharmaceutical company, and assess a few of the ethical marketing challenges faced by the company, thereby seeking evidence as to why these have become an issue for the company.... The study will involve a critical analysis of the poor as well as good marketing ethical practices conducted by glaxosmithkline, thereby highlighting various repercussions encountered by the company.... glaxosmithkline provides pharmaceutical products, which specialize in solving issues related to the central nervous system, respiratory system, urogenital, cardiovascular system, oncology and emesis, anti-virals, antibacterials, rare diseases, metabolic, dermatology, immuno-inflammation, and HIV....
12 Pages (3000 words) Essay

GlaxoSmithKline as the Second Largest Company in the Pharmaceutical Industry

GSK is listed in FTSE 100, FTSE 350 and FTSE All-Share (glaxosmithkline plc.... The paper "glaxosmithkline as the Second Largest Company in the Pharmaceutical Industry" states that the decrease in share price has helped the investor to buy more shares in July 2014 than in July 2013.... Despite the decrease in share price, the company has anticipated growth of 4% to 8% (MarketWatch, 'glaxosmithkline Lowers Full-Year Profit Outlook').... he decrease in this company's financials has affected the earnings per share (EPS), which have dropped by 25% from the previous year's performance (Guardian News and Media Limited, 'FTSE Ends Week On A Low Note, While glaxosmithkline Suggested As Pfizer Target')....
8 Pages (2000 words) Essay
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us